Celldex Therapeutics, Inc. (CLDX)
27.94
-0.25
(-0.89%)
USD |
NASDAQ |
Dec 11, 16:00
28.04
+0.10
(+0.36%)
After-Hours: 06:54
Celldex Therapeutics EPS Diluted (Quarterly): -1.009 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.04M |
| Total Expenses (Quarterly) | 67.04M |
| Enterprise Value | 1.282B |
| Earnings Yield | -12.10% |
| Normalized Earnings Yield | -12.10 |